The novel potential therapeutic target PSMP/MSMP promotes acute kidney injury via CCR2.
Song Z, Yao W, Wang X, Mo Y, Liu Z, Li Q, Jiang L, Wang H, He H, Li N, Zhang Z, Lv P, Zhang Y, Yang L, Wang Y.
Song Z, et al. Among authors: he h.
Mol Ther. 2024 Jul 3;32(7):2248-2263. doi: 10.1016/j.ymthe.2024.05.028. Epub 2024 May 24.
Mol Ther. 2024.
PMID: 38796708